BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1983184)

  • 1. Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity.
    Veerisetty V; Balasubramaniam NK; Gentry GA
    Acta Virol; 1990 Dec; 34(6):568-73. PubMed ID: 1983184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of three 2'-fluoropyrimidine nucleosides and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (BW B759U) against pseudorabies and equine rhinopneumonitis virus infection in vitro and in laboratory animals.
    Rollinson EA
    Antiviral Res; 1987 Jan; 7(1):25-33. PubMed ID: 3026244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
    Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
    Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus: inhibition of replication by three new drugs.
    Lin JC; Smith MC; Cheng YC; Pagano JS
    Science; 1983 Aug; 221(4610):578-9. PubMed ID: 6306771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Fourel I; Hantz O; Watanabe KA; Jacquet C; Chomel B; Fox JJ; Trepo C
    Antimicrob Agents Chemother; 1990 Mar; 34(3):473-5. PubMed ID: 2334160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV1-specific thymidylate kinase activity in infected cells.
    Veerisetty V; Gentry GA
    Intervirology; 1985; 24(1):42-9. PubMed ID: 2995273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.
    De Clercq E; Walker RT
    Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of various 1-beta-D-arabinofuranosyl-E-5-halogenovinyluracils and E-5-bromovinyl-2'-deoxyuridine against salmon herpes virus, Oncorhynchus masou virus (OMV).
    Suzuki S; Machida H; Saneyoshi M
    Antiviral Res; 1987 Feb; 7(2):79-86. PubMed ID: 3034148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of nucleoside analogs by equine herpesvirus type 1 pyrimidine deoxyribonucleoside kinase.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Jan; 7(1):53-67. PubMed ID: 3026247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
    Coen N; Duraffour S; Topalis D; Snoeck R; Andrei G
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7312-23. PubMed ID: 25267682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleosides. 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents.
    Perlman ME; Watanabe KA; Schinazi RF; Fox JJ
    J Med Chem; 1985 Jun; 28(6):741-8. PubMed ID: 4009596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
    Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
    J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents.
    Colacino JM; Lopez C
    Antimicrob Agents Chemother; 1983 Oct; 24(4):505-8. PubMed ID: 6316843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.
    Lin JC; Smith MC; Pagano JS
    Antimicrob Agents Chemother; 1985 Jun; 27(6):971-3. PubMed ID: 2992367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.
    Harada K; Matulic-Adamic J; Price RW; Schinazi RF; Watanabe KA; Fox JJ
    J Med Chem; 1987 Jan; 30(1):226-9. PubMed ID: 3027334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and selectivity of (E)-5-(2-bromovinyl)-2'-deoxyuridine and some other 5-substituted 2'-deoxypyrimidine nucleosides as anti-herpes agents.
    Reefschläger J; Brwolff D; Bärwolff D; Langen P; Rosenthal HA
    Antiviral Res; 1982 May; 2(1-2):41-52. PubMed ID: 6285818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of Aujeszky's disease (pseudorabies) in the mouse by means of nucleoside analogues: bromovinyldeoxyuridine, acyclovir, and dihydroxypropoxymethylguanine.
    Field HJ
    Antiviral Res; 1985 Jun; 5(3):157-68. PubMed ID: 2992370
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.